Inhibrx Biosciences, Inc. Share Price
NASDAQ: INBX | Small CapInhibrx Biosciences, Inc. Stock Performance
Inhibrx Biosciences, Inc. Share Price Today
As of 30 October 2026, Inhibrx Biosciences, Inc.'s share price is $73.44. The stock opened at $72.96, compared to its previous close of $73.61. During today's trading session, Inhibrx Biosciences, Inc.'s share price traded between $72.19 and $75.47, with an average price of $73.83. Over the past 52 weeks, the stock has recorded a high of $153.68 and a low of $57.63. In terms of performance, Inhibrx Biosciences, Inc.'s share price has declined by 42.70% over the last six months and is down 9.62% on a year-on-year basis.
Inhibrx Biosciences, Inc. Share Price Chart
Inhibrx Biosciences, Inc. Quarterly Profit & Loss
All figures in USD
Inhibrx Biosciences, Inc. Annual Profit & Loss
All figures in USD
About Inhibrx Biosciences, Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
Inhibrx Biosciences, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $99.51 | $73.50 | -26.81% |
Sep 2026 | $121.89 | $100.42 | -19.32% |
Aug 2026 | $81.20 | $124.47 | +51.57% |
Jul 2026 | $94.00 | $82.12 | -13.19% |
Jun 2026 | $102.67 | $94.60 | -8.87% |
May 2026 | $129.22 | $103.81 | -19.00% |
Apr 2026 | $68.46 | $128.16 | +90.80% |
Mar 2026 | $72.00 | $67.17 | -9.46% |
Feb 2026 | $76.28 | $74.19 | -3.04% |
Jan 2026 | $81.85 | $76.52 | -3.16% |
Dec 2025 | $82.28 | $79.02 | -6.40% |
Nov 2025 | $78.54 | $84.42 | +3.89% |